Amyloid oligomers: A joint experimental/computational perspective on Alzheimer's disease, Parkinson's disease, type II diabetes, and amyotrophic lateral sclerosis
PH Nguyen, A Ramamoorthy, BR Sahoo… - Chemical …, 2021 - ACS Publications
Protein misfolding and aggregation is observed in many amyloidogenic diseases affecting
either the central nervous system or a variety of peripheral tissues. Structural and dynamic …
either the central nervous system or a variety of peripheral tissues. Structural and dynamic …
Impaired dopamine metabolism in Parkinson's disease pathogenesis
A full understanding of Parkinson's Disease etiopathogenesis and of the causes of the
preferential vulnerability of nigrostriatal dopaminergic neurons is still an unsolved puzzle. A …
preferential vulnerability of nigrostriatal dopaminergic neurons is still an unsolved puzzle. A …
The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability
Alpha-synuclein (αS) is a conformationally plastic protein that reversibly binds to cellular
membranes. It aggregates and is genetically linked to Parkinson's disease (PD). Here, we …
membranes. It aggregates and is genetically linked to Parkinson's disease (PD). Here, we …
Alpha-synuclein aggregation in Parkinson's disease
E Srinivasan, G Chandrasekhar… - Frontiers in …, 2021 - frontiersin.org
Parkinson's disease (PD), a neurodegenerative disorder characterized by distinct aging-
independent loss of dopaminergic neurons in substantia nigra pars compacta (SNpc) region …
independent loss of dopaminergic neurons in substantia nigra pars compacta (SNpc) region …
The docking of synaptic vesicles on the presynaptic membrane induced by α-synuclein is modulated by lipid composition
Abstract α-Synuclein (αS) is a presynaptic disordered protein whose aberrant aggregation is
associated with Parkinson's disease. The functional role of αS is still debated, although it …
associated with Parkinson's disease. The functional role of αS is still debated, although it …
DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson's disease
Dopamine dyshomeostasis has been acknowledged among the determinants of nigrostriatal
neuron degeneration in Parkinson's disease (PD). Several studies in experimental models …
neuron degeneration in Parkinson's disease (PD). Several studies in experimental models …
In situ architecture of neuronal α-Synuclein inclusions
VA Trinkaus, I Riera-Tur, A Martínez-Sánchez… - Nature …, 2021 - nature.com
The molecular architecture of α-Synuclein (α-Syn) inclusions, pathognomonic of various
neurodegenerative disorders, remains unclear. α-Syn inclusions were long thought to …
neurodegenerative disorders, remains unclear. α-Syn inclusions were long thought to …
Lipids shape brain function through ion channel and receptor modulations: physiological mechanisms and clinical perspectives
S Incontro, ML Musella, M Sammari… - Physiological …, 2025 - journals.physiology.org
Lipids represent the most abundant molecular type in the brain, with a fat content of∼ 60%
of the dry brain weight in humans. Despite this fact, little attention has been paid to …
of the dry brain weight in humans. Despite this fact, little attention has been paid to …
VAMP2 regulates phase separation of α-synuclein
A Agarwal, A Chandran, F Raza, IM Ungureanu… - Nature Cell …, 2024 - nature.com
Abstract α-Synuclein (αSYN), a pivotal synaptic protein implicated in synucleinopathies such
as Parkinson's disease and Lewy body dementia, undergoes protein phase separation. We …
as Parkinson's disease and Lewy body dementia, undergoes protein phase separation. We …
The N-terminal acetylation of α-synuclein changes the affinity for lipid membranes but not the structural properties of the bound state
M Runfola, A De Simone, M Vendruscolo… - Scientific Reports, 2020 - nature.com
The aggregation of α-synuclein (αS), a protein abundant at presynaptic terminals, is
associated with a range of highly debilitating neurodegenerative conditions, including …
associated with a range of highly debilitating neurodegenerative conditions, including …